Viropharma, Inc. (VPHM) Misses Q1 EPS by 5c; Guides FY12 Revs Below Views

May 1, 2012 6:30 AM EDT Send to a Friend
Viropharma, Inc. (NASDAQ: VPHM) reported Q1 EPS of $0.37, $0.05 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $135.8 million versus the consensus estimate of $149.16 million.

Sees FY2012 revenue of $450-$500 million, versus the consensus of $502.43 million.

For earnings history and earnings-related data on Viropharma, Inc. (VPHM) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment